Espinheira De Sá Maciel, Patrícia,Teixeira De Castro, Andreia Cristiana,De Jales Monteiro De Sousa, Ana Luísa,Teixeira Esteves, Ana Sofia,Carvalho Sousa, Nuno Jorge
申请号：
AU2016231834
公开号：
AU2016231834A1
申请日:
2016.03.17
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Citalopram or escitalopram, pharmaceutically acceptable salts or derivatives thereof for use in the treatment of neurodegenerative diseases The disclosure subject matter is related to the use of citalopram or escitalopram, pharmaceutically acceptable salts or derivatives thereof, in the treatment of neurodegenerative diseases that are positively influenced by the decrease of protein misfolding and/or aggregation, in particular by oral administration.
